Organon & Co.
OGN · NYSE
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Revenue | $6 | $6 | $6 | $6 |
| % Growth | 2.2% | 1.4% | -2.1% | – |
| Cost of Goods Sold | $3 | $3 | $2 | $2 |
| Gross Profit | $4 | $4 | $4 | $4 |
| % Margin | 58% | 59.8% | 62.8% | 62.2% |
| R&D Expenses | $0 | $1 | $0 | $0 |
| G&A Expenses | $2 | $2 | $1 | $1 |
| SG&A Expenses | $2 | $2 | $2 | $2 |
| Sales & Mktg Exp. | $0 | $0 | $0 | $0 |
| Other Operating Expenses | $0 | $0 | $0 | -$0 |
| Operating Expenses | $2 | $2 | $2 | $2 |
| Operating Income | $1 | $1 | $2 | $2 |
| % Margin | 23.2% | 21.2% | 27.6% | 30.4% |
| Other Income/Exp. Net | -$1 | -$1 | -$1 | -$0 |
| Pre-Tax Income | $1 | $1 | $1 | $2 |
| Tax Expense | -$0 | -$0 | $0 | $0 |
| Net Income | $1 | $1 | $1 | $1 |
| % Margin | 13.5% | 16.3% | 14.9% | 21.4% |
| EPS | 3.36 | 4.01 | 3.61 | 5.33 |
| % Growth | -16.2% | 11.1% | -32.3% | – |
| EPS Diluted | 3.33 | 3.99 | 3.59 | 5.33 |
| Weighted Avg Shares Out | 0 | 0 | 0 | 0 |
| Weighted Avg Shares Out Dil | 0 | 0 | 0 | 0 |
| Supplemental Information | – | – | – | – |
| Interest Income | $0 | $0 | $0 | $0 |
| Interest Expense | $1 | $1 | $0 | $0 |
| Depreciation & Amortization | $0 | $0 | $0 | $0 |
| EBITDA | $2 | $1 | $2 | $2 |
| % Margin | 25.1% | 22.9% | 28.4% | 31.4% |